Interorgan ammonia trafficking in liver disease
Open accessThe DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.
Abstract
Patients with liver disease have reduced urea synthesis capacity resulting in reduced capacity to detoxify ammonia in the liver. The contribution of the gut to the hyperammonemic state observed during liver failure is mainly due to portacaval shunting and not the result of changes in the metabolism of ammonia in the gut. Small intestinal synthesis of ammonia is related to amino acid breakdown, predominantly glutamine, whereas large bowel ammonia production is caused by bacterial breakdown of amino acids and urea. The kidneys produce ammonia but adapt to liver failure in experimental portacaval shunting by reducing ammonia release into the systemic circulation. The kidneys have the ability to switch from net ammonia production to net ammonia excretion. Data from recent studies in patients with cirrhosis of the liver show that the kidneys have a major role in post upper gastrointestinal bleeding hyperammonemia. During hyperammonemia muscle takes up ammonia and plays a major role in (temporarily) detoxifying ammonia to glutamine. Net uptake of ammonia by the brain occurs in patients and experimental animals with acute and chronic liver failure. Insight will be given in recent developments on ammonia lowering therapies which are based on the information of interorgan ammonia trafficking.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Is Glutamine a Conditionally Essential Amino Acid?
Lacey, J. M., & Wilmore, D. W. (2009) · Nutrition Reviews · doi:10.1111/j.1753-4887.1990.tb02967.x · Cited by 808 · cited 3×
“the immune system (Lacey and Wilmore 1990) and plays an important role in the regulation of acid/base balance by providing the most important substrate for renal ammoniagenesis in many mammals (Halperin et al.”
BackgroundInfluentialHepatic, gut, and renal substrate flux rates in patients with hepatic cirrhosis
Owen, O. E., Reichle, F. A., Mozzoli, M. A., Kreulen, T., Patel, M. S., Elfenbein, I. B., Golsorkhi, M., Chang, K. H., Rao, N. S., Sue, H. S., et al. (1981) · Journal of Clinical Investigation · doi:10.1172/jci110240 · Cited by 290 · cited 2×
“1985) and without portasystemic shunts (Owen et al. 1981).”
Background
Cited by
Q's next: the diverse functions of glutamine in metabolism, cell biology and cancer
DeBerardinis, R. J., & Cheng, T. (2010) · Oncogene · doi:10.1038/onc.2009.358 · Cited by 1,365
Sarcopenia from mechanism to diagnosis and treatment in liver disease
Dasarathy, S., & Merli, M. (2016) · Journal of Hepatology · doi:10.1016/j.jhep.2016.07.040 · Cited by 608
Kurtz, C. B., Millet, Y. A., Puurunen, M. K., Perreault, M., Charbonneau, M. R., Isabella, V. M., Kotula, J. W., Antipov, E., Dagon, Y., Denney, W. S., et al. (2019) · Science Translational Medicine · doi:10.1126/scitranslmed.aau7975 · Cited by 399
“Hyper ammonemia occurs when there is a defect in ammoniadetoxifying enzymes, such as in urea cycle disorders (UCDs), or when the liver is damaged, as in cirrhosis (19, 20).”
BackgroundMechanisms, diagnosis and management of hepatic encephalopathy
Prakash, R., & Mullen, K. D. (2010) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2010.116 · Cited by 324
Adeva, M. M., Souto, G., Blanco, N., & Donapetry, C. (2012) · Metabolism · doi:10.1016/j.metabol.2012.07.007 · Cited by 295
Metadata
- Authors
- Olde Damink, S. W. M., Jalan, R., & Dejong, C. H. C.
- Venue
- Metabolic Brain Disease
- Published
- 2008-12-09
- Volume
- 24
- Issue
- 1
- Pages
- 169-181
- ISSN
- 0885-7490 (ISSN-L)
- 1573-7365
- OpenAlex
- W2079074836
- Cited by
- 111
- References
- 2
- FWCI
- 2.54
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Interorgan ammonia trafficking in liver disease. https://app.cochat.ai/papers/10.1007/s11011-008-9122-5
- The paper
- Olde Damink, S. W. M., Jalan, R., & Dejong, C. H. C. (2009). Interorgan ammonia trafficking in liver disease. Metabolic Brain Disease. https://doi.org/10.1007/s11011-008-9122-5
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.